RNA-seq of human osteoclasts treated with anti-MDA or control antibodies

ABSTRACT: Our aim was to understand how the monoclonal anti-malondialdehyde modified protein antibody 146+:01G07 (originally obtained from a synovial B cell from a rheumatoid arthritis patient) modulates osteoclast development.

INSTRUMENT(S): DNBSEQ-G400

ORGANISM(S): Homo sapiens

SUBMITTER: Bence Rethi 

PROVIDER: E-MTAB-11483 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress